Navigation Links
Interspecies Trial Array 1: N Breast, N Prostate, N Lung, N Colon from CHEMICON

ProductsInterspecies Trial Array 1: N Breast, N Prostate, N Lung, N Colon from CHEMICON
Company CHEMICON
Item Interspecies Trial Array 1: N Breast, N Prostate, N Lung, N Colon
Price $119.00
Description Chemicon Select Tissue Arrays are intended for laboratory research use only. The individual tissues were fixed in neutral buffered formalin and embedded in paraffin. Tissue identification and diagnosis was performed by certified pathologists. Tissue cores were removed from their paraffin blocks and relocated into a new recipient paraffin block, in an array pattern, using Chemicons Advanced Tissue Arrayer (ATA-100).
Not for Diagnostic Use.

SPECIFIC TISSUES:
Four Normal Tissues from each species (Mouse, Rat, Rabbit)
One Case of each Tissue
One 2.0mm Core of each Case
TISSUE HETEROGENITY:

Tissues by their nature have three-dimensional heterogeneity. The tissue cores used in constructing this tissue array may not be homogenous in their cellular constituents. Because of this, we insert multiple tissue cores from multiple cases. This strategy helps in obtaining representative samples from each case.

APPLICATION:

Immunohistochemistry (paraffin embedded)
In Situ Hybridization
Info CHEMICONCHEMICON
CHEMICON International, Inc.
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500
Tech Support: 800-437-7500
Fax Number: 800-437-7502
Web Site: http://www.chemicon.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Interspecies Trial Array 2: N Brain, N Liver, N Muscle, N Kidney from CHEMICON
2. Interspecies Trial Array 3: N Pancreas, N Skin, N Spleen, N Ovary from CHEMICON
3. ReBlot™ Plus Kit - Trial from CHEMICON
4. ChemiLucent Plus Western Blot Enhancing Kit (Trial size) from CHEMICON
5. TNT SP6 Coupled Reticulocyte Lysate System, Trial Size from Promega
6. ReBlot Western Blot Recycling Kit - Trial from CHEMICON
7. Assay Diluent Trial Pack from BioFX Laboratories, Inc.
8. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies
9. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Heart from OriGene Technologies
10. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Testis from OriGene Technologies
11. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Brain (adult) from OriGene Technologies
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Antibodies were affinity purified using epitopes specific to PPP1CC immobilized on solid support....
... EPS 3501 XL Power Supply, 1. 3500 ... constant current, constant power, and linear voltage ... to focused equilibrium in IPG strips quickly ... compensate for variations in gel thickness, sample ...
Biology Products:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: